VALN

Valneva SE
14.16
0.6341 (4.69%)

Valneva SE (VALN) Fundamentals

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travellers; one for the prevention of Japanese encephalitis (IXIARO) and the second (DUKORAL) for the prevention of cholera and diarrhoea. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, and third-party products; Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; and Technologies and services which relates to services and inventions at a commercialization stage. The group is based in France and operates internationally.
SHARE INFORMATION
Market Cap$ 978,471,095
Shares Outstanding69,101,066
Float69,101,066
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 395,910,138
Latest Fiscal EPS$ -1.71
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions13
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months1,273
Institutional Holdings Percent0.6%
Institutional Sold Previous 3 Months3,948
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 40.70
52 Week Low$ 9.77
52 Week High Change$ -58.92
21 Day Moving Average$ 14.3049
21 Day Extended Moving Average$ 14.1287
50 Day Moving Average$ 13.9387
50 Day Extended Moving Average$ 14.0725
200 Day Moving Average$ 17.8056
200 Day Extended Moving Average$ 18.5769
10 Day Average Volume8,243
20 Day Average Volume5,544
30 Day Average Volume5,115
50 Day Average Volume4,706
Alpha0.009787
Beta2.7164
Standard Deviation0.312000
R20.263545
7 Day Price Change$ 0.42
7 Day Percent Change3.06%
21 Day Price Change$ 0.1278
21 Day Percent Change0.91%
30 Day Price Change$ 1.44
30 Day Percent Change11.32%
Month to Date Price Change$ 0.7577
Month to Date Percent Change5.65%
Quarter to Date Price Change$ 1.44
Quarter to Date Percent Change11.32%
180 Day Price Change$ -5.68
180 Day Percent Change-28.63%
200 Day Price Change$ -6.09
200 Day Percent Change-30.08%
Year to Date Price Change$ 1.44
Year to Date Percent Change11.32%

Valneva SE (VALN) Key Ratios

PROFITABILITY
EBIT Margin18.1%
EBITDA Margin18.1%
Pre-Tax Profit Margin13.7%
Profit Margin Count-39.65%
Gross Margin56.3%
Profit Margin TOT-39.65%
INCOME STATEMENTS
Revenue$ 244,953,940
Revenue Per Share$ 3.5412
Revenue (3 Years)$ 34.20
Revenue (5 Years)$ 22.48
FINANCIAL STRENGTH
Price to Tangible Book5.80
Total Debt To Equity1.00
Int Coverage5.20
Current Ratio1.30
Leverage Ratio5.60
Quick Ratio0.90
Long Term Debt To Capital0.47
VALUATION MEASURES
PE Ratio5.90
Enterprise Value$ 829,796,228
Price to Sales3.9987
Price to Free Cash-4.50
PE High Last 5 Years0.00
Price To Book5.20
Price To Cash Flow12.70
PE Low Last 5 Years0.00
Price to Tangible Book5.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.60
Invoice Turnover1.90
Assets Turnover0.30
Return Assets10.52
Return on Equity44.51
Return on Capital27.76

Valneva SE (VALN) Profile

PROFILE INFO
Issue TypeAD
SEC Type-
AuditorDeloitte&Associ?s
CEOThomas Lingelbach
Emplyoees762
Last AuditUE
CIK0001836564
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
Address6 Rue Alain Bombard
Gerland Plaza Techsud
Saint-Herblain, 44800
Websitehttps://www.valneva.com
Facsimile-
Telephone+33 228073710
Emailinvestors.relations@vivalis.com


Your Recent History
NASDAQ
VALN
Valneva
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.